Recurrent Episodes of Hypokalaemia during Treatment with Inhaled Beta-2 Agonist Revealing Gitelman Syndrome, an Uncommon Clinical Entity

A 28-year-old female patient was hospitalized for mild–moderate hypokalaemia which was persistent despite discontinuation of beta-2 agonist bronchodilator treatment. Her past medical history was relevant for two episodes of severe hypokalaemia after active inhaled beta-2 agonist treatment for asthma...

Full description

Bibliographic Details
Main Authors: Nery Sablón-González, Yanet Parodis-Lopez, Maria Belen Alonso-Ortiz, Angélica Laurin, Emmanuel Andres, Noel Lorenzo Villalba
Format: Article
Language:English
Published: SMC MEDIA SRL 2022-10-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/3605